Ignite Creation Date:
2024-05-06 @ 4:37 PM
Last Modification Date:
2024-10-26 @ 2:13 PM
Study NCT ID:
NCT05041101
Status:
TERMINATED
Last Update Posted:
2024-06-10
First Post:
2021-09-02
Brief Title:
Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast Cancer
Sponsor:
Organization:
MD Anderson Cancer Center